Melanoma and Skin Cancer Trials - MASC Trials

Melanoma and Skin Cancer Trials - MASC Trials Conquering melanoma and skin cancer through clinical trials We aim to make our clinical trials accessible to all Australians, no matter where they live.

Melanoma and Skin Cancer Trials (MASC Trials) specialises in investigator-initiated melanoma and skin cancer research. We work collaboratively with world-leading researchers to deliver clinical trials that improve melanoma and skin cancer outcomes. Since 1999, the high-quality evidence published from our trials has changed clinical practice to impact the lives of patients and improve how doctors p

revent, diagnose and treat melanoma and skin cancer. Our network of over 2,250 healthcare professionals and consumers spans all Australian metropolitan cities and many regional towns, with trials currently running at 111 institutions around the world. To learn about our research, including clinical trials that are currently enrolling participants, visit our website: https://www.masc.org.au/

💛 R U OK?A simple question, genuine listening and ongoing support can make all the difference. Take a moment to check in...
10/09/2026

💛 R U OK?

A simple question, genuine listening and ongoing support can make all the difference. Take a moment to check in with someone in your world today.

Are you OK?

💛

A great day at the PC4 2026 Scientific Symposium in Adelaide, connecting with colleagues and partners from across the ca...
09/09/2026

A great day at the PC4 2026 Scientific Symposium in Adelaide, connecting with colleagues and partners from across the cancer care and research community.

Thank you to Dr Janelle Jones, National Manager of PC4 (Primary Care Collaborative Cancer Clinical Trials Group) and host of the symposium, for bringing together such a diverse group of researchers, clinicians, consumers and sector leaders.

It was a pleasure also catch up with Susan Goode (TROG Cancer Research), and Jonathan Godin (Cancer Australia) and discuss the opportunities ahead for collaboration in comprehensive cancer care.

Looking forward to continuing these important conversations and partnerships that support better outcomes for patients and communities.

A milestone in melanoma research🎉We're excited to share that The Alfred has enrolled the first participant in the BETTER...
07/09/2026

A milestone in melanoma research🎉

We're excited to share that The Alfred has enrolled the first participant in the BETTER trial.

Led by Dr Malaka Ameratunga and sponsored by Monash University, the BETTER trial is investigating a new treatment approach for people with melanoma that has spread to the brain.

Melanoma brain metastases can be particularly challenging to treat, and patients are often excluded from clinical trials. This study aims to improve treatment options and quality of life by combining immunotherapy with targeted radiotherapy.
A huge thank you to the Australian Skin Cancer Foundation and everyone who has supported the Mission Melanoma campaigns. Your fundraising efforts are helping make research like this possible.

Congratulations to the research team, clinicians, and supporters who have helped reach this important milestone.

https://www.masc.org.au/better/
https://www.australianskincancerfoundation.org/how-we-fund-research

📣Speaker Program Available - Melanoma and Skin Cancer Trials 2026 Scientific Meeting Featuring presentations by:📌 Austra...
04/09/2026

📣Speaker Program Available - Melanoma and Skin Cancer Trials 2026 Scientific Meeting

Featuring presentations by:

📌 Australian and international leaders in melanoma and skin cancer clinical trials
📌 Consumer advocates
📌 Industry professionals

The 2026 Scientific Meeting promises to foster further innovative research and collaboration while providing exclusive networking opportunities. Check out the full program here: https://www.masc.org.au/sm-2026/

Haven't registered? Seats are limited, so get in quick! Register now via the AMC registration portal: https://www.melanoma2026.com/registration

We're excited to be attending the Australasian Melanoma Conference 2026 (AMC2026), hosted by Peter Mac and Alfred Health...
12/08/2026

We're excited to be attending the Australasian Melanoma Conference 2026 (AMC2026), hosted by Peter Mac and Alfred Health at Melbourne's Sofitel on Collins from 19-21 November.

Visit our exhibition booth to meet our team and discover how we can support your research journey, from concept development and grant applications through to clinical trial operations.

Secure your place today: https://bit.ly/4xrMCHW for our Scientific Meeting on 19 November, followed by AMC2026 on 20-21 November.

Early bird registrations close Friday 14 August.

🎉Tomorrow is World Ophthalmologist Day! At Melanoma and Skin Cancer Trials we are especially grateful for the ophthalmol...
07/08/2026

🎉Tomorrow is World Ophthalmologist Day! At Melanoma and Skin Cancer Trials we are especially grateful for the ophthalmologists contributing to research and clinical trials for ocular melanoma.

We would like to highlight the work of our special interest group, AOMA, who collaborate to improve treatment options and outcomes for ocular melanoma.

👁️Find out more here:

Seats are limited - get in early! Join us in Melbourne for the 2026 Melanoma and Skin Cancer Trials Scientific Meeting -...
21/07/2026

Seats are limited - get in early!

Join us in Melbourne for the 2026 Melanoma and Skin Cancer Trials Scientific Meeting - a satellite meeting of the 2026 Australasian Melanoma Conference.

🗓️ 19 November - Melanoma and Skin Cancer Trials Annual Scientific Meeting
🗓️ 19-21 November - Australasian Melanoma Conference (AMC)

Registrations are OPEN for one or both meetings through the AMC registration portal (link below). Early bird registration closes 31 July.
https://www.melanoma2026.com/registration

Today is Rare Cancers Awareness Day. Since 2021, the 26th of June has marked a national day of recognition, support and ...
26/06/2026

Today is Rare Cancers Awareness Day. Since 2021, the 26th of June has marked a national day of recognition, support and understanding for those affected by rare and less common cancers.

At Melanoma and Skin Cancer Trials, we are proud to support and represent those diagnosed with rare cancers, specifically Merkel Cell Carcinoma and Ocular Melanoma within our Consumer Advisory Panel. We would like to acknowledge and thank all the patients who have shared their cancer stories with MASC Trials, your courage is deeply appreciated.

You can read some incredible patient stories here: https://www.masc.org.au/our-stories/
Learn more about Rare Cancers Awareness Day 2026 here: https://www.rare.org.au/

MASC Trials is proud to represent 2 special interest priority research groups, AMIGO’s and AOMA, dedicated to improving treatment options and outcomes for patients diagnosed with Merkel Cell Carcinoma and Ocular Melanoma.

Learn more about AMIGO’s here: https://amigos.org.au/about-us/
Learn more about AOMA here: https://www.masc.org.au/ocular-melanoma/

💙 💙

🎉 A big THANK YOU to everyone who joined our Concept Development Workshop! It was fantastic to see such strong participa...
25/06/2026

🎉 A big THANK YOU to everyone who joined our Concept Development Workshop!

It was fantastic to see such strong participation and energy throughout the session — your engagement truly made the experience special.

We were also incredibly fortunate to bring together four amazing presenters, including two consumers (Alison and Michelle) alongside Dr Ashray Gunjur and Dr Jenny Morris. The depth and diversity of perspectives created a powerful and meaningful conversation.

We’re grateful to have such a passionate and open community, and we look forward to continuing the conversation and seeing you at future sessions!

Address

553 St Kilda Road
Melbourne, VIC
3004

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+61399039022

Alerts

Be the first to know and let us send you an email when Melanoma and Skin Cancer Trials - MASC Trials posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share